Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen

This publication has 18 references indexed in Scilit:

• The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer Patients
  JNCI Journal of the National Cancer Institute, 1994
• bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer
  British Journal of Cancer, 1994
• p53 In tumour pathology: Can we trust immunohistochemistry?—revisited!
  The Journal of Pathology, 1994
• Expression of bcl-2-like immunoreactivity in the normal breast and in breast cancer
  The Breast, 1993
• Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections
  The Journal of Pathology, 1992
• Comparison of Four Immunochemical Methods For the Measurement of Oestrogen Receptor Levels In Breast Cancer
  Cytopathology, 1992
• Mitochondrial protein p26 BCL2 reduces growth factor requirements of NIH3T3 fibroblasts*1
  Experimental Cell Research, 1991
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
  Nature, 1990
• Expression in Non-Hodgkin's Lymphoma of thebcl-2 Protein Associated with the t(14;18) Chromosomal Translocation
  New England Journal of Medicine, 1988
• “Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A
  Analytical Biochemistry, 1981